Infectious DiseaseEmergency Medicine
Returning Traveller — Fever
Travel history + targeted workup, malaria first, isolation for VHF risk, notification of NaTHNaC / Public Health.
Source: NaTHNaC; PHE; ESCMID 2018
Step 1 of ~11
info
Travel History Essential
Detailed travel history within 12 months: countries, rural vs urban, accommodation, water/food exposure, freshwater swimming, animal contacts (bites, bats), insect bites, sexual contacts, healthcare contact (in TB / VHF endemic areas), prophylaxis taken (and adherence), vaccinations.
Assess: incubation period (last possible exposure), nature of fever (continuous, intermittent, pattern), associated features (rash, neurological, GI, jaundice, respiratory).
Isolate in side room until VHF risk assessment complete.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Paracetamol (Paediatric) · Analgesic / Antipyretic — First-Line Pain and Fever in Children
- Inclisiran · PCSK9-targeted siRNA
- Promethazine hydrochloride · First-generation H1-antihistamine (phenothiazine)
- Tolbutamide · First-generation sulfonylurea (short-acting)
- Chlorphenamine (Chlorpheniramine) · Sedating Antihistamine (H1 Antagonist — First-generation)
- Cyproheptadine hydrochloride · First-generation antihistamine + 5-HT₂A antagonist
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Neutropenic Sepsis · NICE CG151; ASCO 2018
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023
Decision support only. Always apply local guidelines and clinical judgement.